Catalyst Database

Chronological list of catalyst events. Click "See Drug Details" to view detailed info in our AmpCard. Use the Sort options or search box below (e.g. "COVID") to filter the catalyst results.

Sort Table By:

Drug | Disease (links)

Date | Stage

Volatility

VKTX

August 28, 2020

VK2809

Non-Alcoholic Fatty Liver Disease (NAFLD)

Phase 2 (Efficacy Data at EASL)

Amp Volatility Score:

GTHX

August 2020

Trilaciclib (G1T28)

Small Cell Lung Cancer (SCLC)

NDA Accepted for Review / PDUFA date assignment

Amp Volatility Score:

AMRN

9/2/2020

Vascepa

Cardiovascular Disease / Triglycerides

ANDA Litigation

Amp Volatility Score:

41%

IBIO

Q3 2020

IBIO-200/201

COVID-19 Vaccine

Preclinical

Amp Volatility Score:

TEST

Phase Alpha Sigma

TESTER

testing

buick

Amp Volatility Score:

VNDA

September 2020

Tradipitant | ODYSSEY VLY-686-3501

COVID-19

Phase 3 (Interim Analysis & Safety and Efficacy Data)

Amp Volatility Score:

HGEN

September 2020

Lenzilumab

COVID-19

Phase 3 (Interim Analysis)

Amp Volatility Score:

GTHX

Q3 2020

Lerociclib (+ fulvestrant)

ER+, HER2- BC

Phase 1/2 (Safety & Efficacy Data)

Amp Volatility Score:

DVAX

September 30, 2020 (Est)

SCB-2019

COVID-19 Vaccine

Phase 1 (Preliminary safety and immunogenicity results)

Amp Volatility Score:

ZGNX

September 2020

ZX008

Lennox-Gastaut syndrome

sNDA Submission (Meeting with FDA)

Amp Volatility Score:

39%

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon